Clinical trial
Dexamethasone in Total Knee Arthroplasty: What Dose Should we be Giving Patients Intraoperatively
NCT05018091 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexamethasone in Total Knee Arthroplasty: What Dose Should we be Giving Patients Intraoperatively
- Lead sponsor
- Rush University Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 28, 2021
- Completion date
- May 30, 2025
- Enrollment
- 438 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
total knee arthroplasty